Paul R. Afolabi

Synbiotics Alter Fecal Microbiomes, But Not Liver Fat or Fibrosis, in a Randomized Trial of Patients With Nonalcoholic Fatty Liver Disease

Eleonora Scorletti, Paul R. Afolabi, Elizabeth A. Miles et al. · Gastroenterology · 2020 · 208 citations · Full text

Dysbiosis, Microbiota, Gut Microbiology +7

Site-Directed Mutagenesis and X-ray Crystallography of the PQQ-Containing Quinoprotein Methanol Dehydrogenase and Its Electron Acceptor, Cytochrome <i>c</i>_L^,

Paul R. Afolabi, Fiyaz Mohammed, K Amaratunga et al. · Biochemistry · 2001 · 73 citations

Design and rationale of the INSYTE study: A randomised, placebo controlled study to test the efficacy of a synbiotic on liver fat, disease biomarkers and intestinal microbiota in non-alcoholic fatty liver disease

Eleonora Scorletti, Paul R. Afolabi, Elizabeth A. Miles et al. · Contemporary Clinical Trials · 2018 · 36 citations · Full text

Metabolic Syndrome, Probiotic, Dysbiosis +12

Growth differentiation factor-15 and the association between type 2 diabetes and liver fibrosis in NAFLD

Josh Bilson, Eleonora Scorletti, Laure B. Bindels et al. · Nutrition and Diabetes · 2021 · 31 citations · Full text

The effect of total starvation and very low energy diet in lean men on kinetics of whole body protein and five hepatic secretory proteins

Paul R. Afolabi, Farook Jahoor, Alan A. Jackson et al. · American Journal of Physiology-Endocrinology and Metabolism · 2007 · 27 citations

Nutrition, Caloric Restriction, Metabolic Syndrome +19